PATIENTENPOSITIONIERUNGSVORRICHTUNG

Patent europeic · EP3684258 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3684258
Numer da la dumonda
EP18859167
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-09-2018
Publitgà
29-07-2020
Concedì
25-02-2026
La protecziun finescha il pli tard
13-09-2038
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
A61B 6/04 (2006.01)
A61N 5/10 (2006.01)
Prioritad
AU 2017903847 21.09.2017
Dumonda PCT
PCT/AU2018/051008 14.09.2018
Publicaziun PCT
WO2019/056055 28.03.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-02-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.02.2026

Partidas

Possessur

Leo Cancer Care, Inc.

7921 UW Health Court, Middleton, WI 53562, US

Inventur

FEAIN, Ilana

Eveleigh, New South Wales 2015, AU

TOWE, Stephen

Lewes BN7 1LE, GB

STRANGEMAN, Mark

Haywards Heath, West Sussex RH16 4PE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.